Tugwell, Peter2; Boers, Maarten2; D'Agostino, Maria-Antonietta2; Beaton, Dorcas2; Boonen, Annelies2; Bingham, Clifton O2; Choy, Ernest2; Conaghan, Philip G2; Dougados, Maxime2; Duarte, Catia2; Furst, Daniel E2; Guillemin, Francis2; Gossec, Laure2; Heiberg, Turid2; van der Heijde, Désirée M2; Hewlett, Sarah2; Kirwan, John R2; Kvien, Tore K2; Landewé, Robert B2; Mease, Philip J2; Østergaard, Mikkel1; Simon, Lee2; Singh, Jasvinder A2; Strand, Vibeke2; Wells, George2
1 Videncenter for Reumatologi og Rygsygdomme, HovedOrtoCentret Rigshospitalet, Rigshospitalet, The Capital Region of Denmark2 unknown
implications of filter 2.0 to select outcome instruments through assessment of "truth": content, face, and construct validity
OBJECTIVE: The Outcome Measures in Rheumatology (OMERACT) Filter provides guidelines for the development and validation of outcome measures for use in clinical research. The "Truth" section of the OMERACT Filter requires that criteria be met to demonstrate that the outcome instrument meets the criteria for content, face, and construct validity. METHODS: Discussion groups critically reviewed a variety of ways in which case studies of current OMERACT Working Groups complied with the Truth component of the Filter and what issues remained to be resolved. RESULTS: The case studies showed that there is broad agreement on criteria for meeting the Truth criteria through demonstration of content, face, and construct validity; however, several issues were identified that the Filter Working Group will need to address. CONCLUSION: These issues will require resolution to reach consensus on how Truth will be assessed for the proposed Filter 2.0 framework, for instruments to be endorsed by OMERACT.
Journal of Rheumatology, 2014, Vol 41, Issue 5, p. 1000-4